that is not associated with fibrillarin.
The 18S, 5.8S, and 25/28S rRNAs are synthesized in the nucleolus as a single precursor RNA (pre-rRNA) which contains additional sequences that are discarded during RNA maturation. Processing of the pre-rRNA is a complex process involving many RNA intermediates and cleavage events, which frequently follow alternative pathways. The substrate for processing is a large ribonucleoprotein structure containing tens of ribosomal proteins and nucleolar accessory factors associated with nascent pre-rRNA (reviewed in references 10, 53, 60, and 61).
Nucleoli contain a large number of metabolically stable 60-to 260-nucleotide (nt)-long RNA species, referred to as small nucleolar RNAs (snoRNAs) (reviewed in references 13, 14, 37, and 53) . Some of these RNAs, e.g., U3, U8, and U13, are transcribed from independent transcription units and contain 5Ј-terminal trimethylguanosine caps. Most snoRNAs, however, are processed from introns of pre-mRNAs (32; reviewed in references 13, 37, and 52) and contain a monophosphate at the 5Ј end (24, 42, 57) , consistent with their processing from longer precursor RNAs.
Several snoRNAs have been demonstrated to participate in the processing of pre-rRNA. The U3 snoRNA is involved in the earliest cleavage event, which occurs in the 5Ј external transcribed spacer (19, 21, 41) , and its depletion impairs the accumulation of mature 18S rRNA in the yeast Saccharomyces cerevisiae and vertebrates (19, 50) . snoRNAs U14, snR10, and snR30 in S. cerevisiae (33, 39, 54) and U22 in Xenopus laevis (58) are also essential for 18S rRNA processing, while 7-2/ MRP RNA and U8 snoRNA are involved in a maturation of 5.8S rRNA in S. cerevisiae (9, 35, 51) and 28S rRNA in X. laevis (43) , respectively. On the basis of their association with prerRNAs or with nascent ribosomal particles, other snoRNAs may also participate in pre-rRNA processing or other aspects of ribosome biogenesis in the nucleolus (1, 2, 14, 37, 53, 60) .
The snoRNAs are complexed with proteins, forming small ribonucleoprotein particles (snoRNPs) (reviewed in references 3, 37, and 53). Most of the snoRNPs in yeast and vertebrate cells have a common phylogenetically conserved nucleolar protein, fibrillarin (37, 53, 60) . In vertebrates, all snoRNAs of this class contain two short conserved sequence motifs, boxes C (or CЈ) and D (37, 56, 57) , which are essential, either directly or indirectly, for binding of fibrillarin and for RNA accumulation (3, 37, 44) .
A small group of nucleolar RNAs that are not associated with fibrillarin comprises 7-2/MRP RNA and three snoRNAs identified recently in vertebrates: U17/E1, E2, and E3. The 7-2/MRP RNA is a component of RNase MRP, which cleaves the pre-rRNA in a region upstream of the 5.8S rRNA in S. cerevisiae. The 7-2/MRP RNA is structurally related to the RNA component of RNase P, and both RNAs are associated with the same nucleolar protein, the Th/To antigen (reviewed in references 37 and 40) . snoRNAs U17/E1 (8, 24, 48) and E2 and E3 (48) share no obvious structural elements, and the proteins associated with them remain unknown. The function of these snoRNAs has not been established, but the finding that they can be cross-linked to the pre-rRNA (47) suggests that they are involved in ribosome biogenesis. In this work, we report the characterization of a novel non-fibrillarin-associated snoRNA, named U19, identified in human and mouse cells.
MATERIALS AND METHODS
General procedures. Unless indicated otherwise, all techniques used for cloning and sequencing of DNA and for manipulating RNA and oligonucleotides were as described by Sambrook et al. (49) . The following oligonucleotides were used in this study : A, GTTTGCACCCAGACTAGGATCAACTCC; B, GAGA  GTGGAATGACTCCTGTGGAG; C, ATAGGATCCTGGTCCAGCAGTTG  TCAGC; D, TGTAATACGACTCACTATAGGATCCAGCGGTTGTCAGCT;  E, AATATTGTTTGCACCCAGACT; F, AGTGCTTGGAGCCAAACCTCAA  TAA; G, GAUGACUUGAAAGUAGGGC; H, CUUAUCUUGGUGUCACA CAG; I, GTGATCGATCATCCAGCGGTTGTC; and J, CCACTCGAGAAAA  AAATTGTTTGCACCTCGACTAG. Characterization of U19 RNA. HeLa cell nuclear RNA (27) was fractionated by polyacrylamide gel electrophoresis (PAGE) on a denaturing 8 M urea-8% polyacrylamide gel. RNAs migrating between U2 (187-nt-long) and U3 (217-ntlong) snRNAs were recovered and 3Ј end labeled with [5Ј-32 P]cytidine 3Ј,5Ј-bisphosphate (pCp) and T4 RNA ligase (11) . Radiolabeled RNA was again fractionated on an 8 M urea-polyacrylamide gel, and an approximately 200-ntlong RNA, referred to hereafter as U19, was eluted from a gel. Chemical sequencing (28) yielded a sequence of 45 nt proximal to the 3Ј end. The middle and 5Ј-proximal sequence of U19 RNA was determined by dideoxy sequencing, using HeLa cell nuclear RNA as a template and the 5Ј-end-labeled oligonucleotide complementary to nucleotides 170 to 196 of U19 RNA (oligonucleotide A) as a primer for avian myeloblastosis reverse transcriptase (38) . The nature of the 5Ј-terminal residue was established by cloning of the U19 cDNA. The 3Ј-terminal sequence of U19 RNA was determined by the oligoribonucleotide ligation-PCR amplification procedure (24) . The oligonucleotide corresponding to positions 150 to 168 of the U19 RNA (oligonucleotide B) was used as the upstream primer. Partial cDNAs containing sequences of human and mouse U19 RNAs, lacking four and three 3Ј-terminal residues, respectively, were generated by a PCR-based procedure which involves tagging of the cDNA 3Ј end with an oligonucleotide of known sequence (24) . Oligonucleotide A was used as a downstream primer, and the HeLa cell nuclear RNA and mouse NIH 3T3 cell total RNA were used as templates for reverse transcription. PCR-amplified fragments were inserted into the SmaI site of pBluescribe, yielding plasmids pHU19/cDNA and pMU19/ cDNA. A mouse full-length U19 cDNA was obtained by the oligoribonucleotide ligation-PCR amplification procedure (24) , using an oligonucleotide specific to the 5Ј-terminal region of mouse U19 RNA and containing the BamHI site (oligonucleotide C) as the upstream primer. The amplified fragment was cloned into the BamHI site of pBluescribe, yielding pMU19/cDNAf. The 32 P-labeled antisense probe transcribed from pMU19/cDNAf was used for RNase A-RNase T 1 mapping with the NIH 3T3 cell RNA. The resulting protected fragment had a length similar to that of the mouse U19 RNA identified by Northern (RNA) analysis, thus further verifying the sequence of the RNA (data not shown).
To circularize U19 RNA, 10 g of HeLa nuclear RNA was incubated with 50 U of T4 RNA ligase at 4ЊC for 48 h in a 500-l reaction mixture under conditions described by Goodall et al. (15) . Half of the RNA sample was gently treated with alkali (29) , and RNAs were fractionated on a denaturing 8% polyacrylamide gel. Linear and circular forms of U19 RNA were visualized by Northern analysis using labeled U19 cDNA as a probe. Circularization of the in vitro processed product c was performed as described previously (24) .
Secondary structure probing. The coding region of U19 RNA was cloned behind the T7 RNA polymerase promoter by using PCR as follows. The 5Ј primer (oligonucleotide D) contained 5Ј-terminal 18 nt of U19 RNA preceded by the sequence of the T7 RNA polymerase promoter. The 3Ј primer (oligonucleotide E) had an 18-nt sequence complementary to the 3Ј end region of U19 RNA followed by the SspI restriction site. HeLa cell DNA was used as a template. The amplified fragment was cloned into the SmaI site of pUC19, resulting in pU19cod/T7. In vitro synthesis of U19 RNA was carried out as described previously (15) . The resulting U19 RNA transcript contains two additional G residues at the 5Ј end and lacks one U residue at the 3Ј end.
The 3Ј end of the in vitro-synthesized U19 RNA was labeled with [5Ј-32 P]pCp by using T4 RNA ligase (11) . The 5Ј end was labeled with [␥- 32 P]ATP and T4 polynucleotide kinase after prior treatment of RNA with calf intestine phosphatase. The RNA was purified by PAGE (6% gel) and used for the secondary structure probing under nondenaturing conditions (10 mM Tris-HCl [pH 7.5], 10 mM MgCl 2 , 50 mM KCl) as described by Krol and Carbon (30) .
Characterization of the human U19 locus. Sequences flanking the U19 RNA coding region in the genome were cloned by inverse PCR (55), using as a template 10 g of the HeLa cell DNA partially digested with Sau3A and circularized by T4 DNA ligase. Oligonucleotides B (see above) and F, complementary to nt 78 to 92 of U19 RNA, were used as primers. Amplified DNA fragments were size fractionated on a 1% agarose gel. Six fragments of increasing length were cloned into the SmaI site of pBluescribe. All clones were subjected to sequence analysis. Two cDNA fragments specific for spliced transcripts of the U19 RNA host gene were cloned by reverse transcription-PCR (22) . A cDNA obtained by randomly primed reverse transcription of poly(A) ϩ RNA from HeLa cells was used as a PCR template, and oligonucleotides G and H, specific for exons situated upstream and downstream of the U19 coding region, were used as primers. The primers were selected on the basis of results of RNase A-RNase T 1 mappings performed with HeLa cell poly(A) ϩ RNA and antisense RNA probes specific for regions flanking the U19 coding sequence (see below).
Southern analysis. HeLa cell DNA (10 g) was digested with restriction nuclease Sau3A, DdeI, or HaeIII and processed as described previously (49) . Hybridization to the U19 cDNA probe was carried out in a solution containing 6ϫ SSC (1ϫ SSC is 0.15 M NaCl plus 0.015 M sodium citrate), 50% formamide, 0.5% sodium dodecyl sulfate (SDS), and 100 g of salmon sperm DNA per ml at 46ЊC for 18 h. The washing was at 60ЊC in 0.1ϫ SSC-0.5% SDS.
In vitro processing of U19 RNA. An RNA transcript containing the human U19 RNA sequence, 74 nt of upstream and 107 nt of downstream intronic flanking sequences, and 6 and 2 nt originating from the vector at the 5Ј and 3Ј ends, respectively (for sequences, see the legend to Fig. 4 ) was generated from linearized pU17/T7 (25) . Processing was carried out in the HeLa cell extract as described previously (24) .
Processing of U19 RNA in transfected mouse cells. Plasmids pG CXM and pR have been described elsewhere (25) . To obtain pR M , the coding region of U19 RNA was PCR amplified by using primers I and J, specific for the 5Ј-and 3Ј-terminal regions of U19 RNA, respectively. Use of these primers resulted in introduction of a TG-to-GA mutation at positions 186 and 187 of U19 RNA and also led to inclusion of the ClaI and XhoI sites flanking the mutated U19 RNA coding region (see Fig. 5B ). The amplified fragment was inserted between the ClaI and XhoI sites of pG CXM , yielding pR M . Transfection of mouse L929 (ATCC CCL1) cells (16) and isolation of RNA (15) were performed as described previously.
Cell fractionation, preparation of extracts, immunoprecipitation, and glycerol gradient analysis. Fractionation of HeLa cells and RNA isolation were performed as described previously (27, 56) . To extract nucleolar RNPs, the nucleolar fraction obtained from 3 ϫ 10 8 HeLa cells was resuspended in 2 ml of extraction buffer containing 10 mM Tris-HCl (pH 7.4), 10 mM NaCl, 10 mM dithiothreitol, 50 g of yeast tRNA per ml, and 40 U of RNasin per ml. The mixture was incubated on ice for 20 min with occasional shaking and centrifuged for 10 min at 10,000 ϫ g. The supernatant was layered on a 10 to 30% glycerol gradient containing 10 mM Tris-HCl (pH 7.4) and 10 mM NaCl and centrifuged at 25,000 rpm for 12 h at 4ЊC in a TST41 Kontron rotor.
Preparation of HeLa cell extracts and their use for immunoprecipitations of snoRNPs with an antibody against fibrillarin (antibody 72B9 [46] ) were performed essentially as described previously (31) except that extraction and immunoprecipitation were done in the presence of 200 mM NaCl. RNA from HeLa subcellular fractions, from glycerol gradient fractions, and from immunoprecipitates was extracted as described previously (26, 27) .
RNase A-RNase T 1 mapping. Mapping was performed as described previously (15) . Specific complementary RNA probes were synthesized in vitro by T3 or T7 RNA polymerase, using [␣- 32 P]CTP (30 to 40 Ci/mmol) and linearized plasmids as templates. RNA probes used for mapping of human U3, U4, U13, and 7-2/MRP RNAs were as described previously (24, 25, 27) . EcoRI-linearized pHU19/cDNA served as a template for the preparation of the U19-specific probe. RNase mapping of the in vitro processing products was performed with unlabeled antisense RNA probes as described previously (24) . An RNA probe specific to the 3Ј-end region of U19 RNA was transcribed from RsaI-cut pU19/ T7. To obtain a 5Ј-end-specific probe, the EcoRI-RsaI fragment of pU19/T7 was inserted into the EcoRI-SmaI sites of pBluescribe, and the resulting plasmid, pU19/PR5Ј, was linearized with EcoRI.
Nucleotide sequence accession numbers. Sequences of the human and mouse U19 RNAs are deposited in the EMBL, GenBank, and DDBJ databases under accession numbers X94290 and X94291, respectively.
RESULTS
Characterization of human U19 RNA. A novel snoRNA, named U19, was identified in a nuclear RNA preparation from human HeLa cells, and partial sequence of the 3Ј region was obtained by chemical and dideoxy sequencing of RNA. The 3Ј-terminal sequence, which was not unambiguously established by chemical sequencing, was determined by an oligoribonucleotide ligation-PCR amplification procedure (Fig. 1A) . The primary structure of U19 RNA was further confirmed by cloning and sequencing of the U19 cDNA and its genomic locus (see below). Human U19 RNA is 200 nt long (Fig. 1C ) and exhibits no significant sequence similarity to any mammalian or yeast snoRNA characterized to date.
Three lines of evidence indicate that the 5Ј terminus of U19 RNA is not capped but contains a monophosphate and that a free hydroxyl is present at the 3Ј end: (1) antibodies directed against trimethylguanosine or 7-methylguanosine cap structures did not precipitate the RNA (data not shown); (ii) phosphorylation of the 5Ј end of U19 RNA in the presence by T4 polynucleotide kinase and [␥-32 P]ATP depended upon pretreatment of RNA with calf intestine phosphatase ( Fig. 4C and data not shown; and (iii) incubation of U19 RNA with T4 RNA ligase, an enzyme which requires RNA substrates bearing a 5Ј-monophosphate and 3Ј-OH termini (11) , resulted in formation of a covalently closed circular isoform of the RNA having a characteristic slow mobility in a denaturing gel (Fig. 1B, ligase-catalyzed reactions (see above) also indicate that it contains free 3Ј hydroxyl. A proposed secondary structure for U19 RNA. Since U19 is a nonabundant RNA (see below), an in vitro-transcribed rather than a native RNA was used for probing its structure. The RNA labeled at either the 5Ј (Fig. 2A) or the 3Ј (Fig. 2B ) end was treated under nondenaturing conditions with nucleases specific for either single-stranded (RNases T 1 and A and nuclease S1) or double-stranded (nuclease V1) regions (30) . A summary of the structure probing experiments and the derived secondary structure model for U19 RNA are shown in Fig. 2C . The calculated free energy of the proposed RNA structure is Ϫ67.5 kcal (ca. Ϫ282.4 kJ)/mol. The three major hairpin regions are designated helices I, II, and III. The single-stranded nature of the terminal loops (A, B, and C) and of the major internal bulge-loop structures in the hairpins is well supported by cleavages with the single-strand-specific enzymes. Since nucleotides 148-CUG-150 and 181-UAG-183 in the internal bulge-loop of stem III exhibited reactivity to both single-and double-strand-specific nucleases, it is possible that this region assumes two alternative conformations.
To obtain additional support for the proposed secondary structure, we have characterized a sequence of U19 RNA from mouse NIH 3T3 cells. Mouse RNA (Fig. 2D ) has 86% homology with its human equivalent and can be folded into a secondary structure similar to that proposed for human U19 RNA. Sequence differences are found mainly in singlestranded regions (U-1, G-2, G-3, G-30, A-43, G-51, U-68, C-82, C-131, U-168, G-178, and G-183). Most of the alterations in double-stranded regions (e.g., A-10, C-78, C-90, A-132, U-145, and C-147) are compatible with postulated stems, although some changes (e.g., C-40 and C-46) disrupt continuity of short helices. Determination of U19 RNA sequences from other organisms and additional structure probing experiments are required to refine the proposed model. U19 RNA is encoded within an intron. To determine the structure of the U19 RNA gene, the HeLa cell DNA was digested with restriction endonucleases HaeIII, Sau3A, and DdeI and hybridized to the U19 cDNA as a probe. Sequences encoding U19 RNA were found to reside in a single restriction fragment (Fig. 3A) . Since, in addition, no evidence of sequence isoforms of U19 RNA was obtained from direct RNA sequencing or during the cloning of human U19 cDNAs, it appears that U19 RNA in humans is encoded by a single-copy gene.
The U19 gene was characterized by inverse PCR using partially digested and circularized HeLa cell genomic DNA. A physical map of the gene, deduced from the sequencing of amplified DNA fragments and supported by the results of additional PCR and RNase A-RNase T 1 mapping analyses (see below; also data not shown), is presented in Fig. 3B . Inspection of the flanking and coding regions of the U19 RNA revealed no upstream or intragenic promoter elements important for transcription of U small nuclear RNA (snRNA), tRNA, or 5S rRNA genes in mammals (17, 62) . Hence, U19 RNA may represent a new member of the family of intronencoded snoRNAs, a possibility supported by the fact that its 5Ј end has a monophosphate group, likely a result of its processing from longer precursor RNA (24, 57) .
Searching of the databases with sequences of the U19 locus failed to identify the host gene of U19 RNA. However, RNase A-RNase T 1 mapping experiments detected two putative exon regions situated upstream and downstream of the U19 coding region (see the legend to Fig. 3B ). Using reverse transcription-PCR, we identified two alternative donor splice sites and the acceptor splice site upstream and downstream of the U19 coding region, respectively (Fig. 3B) . The sequences of the 157-and 245-nt-long amplified cDNA fragments representing two alternatively spliced RNAs were identical with the sequence of genomic DNA, indicating that the cDNAs originate from the U19 locus. Both cDNA sequences contain multiple translation termination signals in all three reading frames (unpublished observation). This finding suggests that the intron harboring the U19 sequence is located in the region flanking the proteincoding sequence or that the transcript of the U19 RNA host gene does not code for the protein (58, 59) .
In vitro processing of U19 RNA. An internally 32 P-labeled RNA transcript containing the U19 RNA region flanked by upstream and downstream intron sequences was incubated with the HeLa cell extract (Fig. 4A) . Several RNA products, accumulating in a time-dependent fashion, were identified. Their structures were determined by RNase A-RNase T 1 mapping using unlabeled RNA probes complementary to either the 5Ј or 3Ј portion of the processing substrate (Fig. 4B) . Two major products, a5Ј and a3Ј, accumulating early were found to correspond to RNA processed at only the 5Ј and 3Ј ends, respectively. The presence of such products indicates that processing reactions at both ends are independent of each other. Product b, appearing after 20 min of incubation, represents RNA fully processed at the 5Ј end but still containing a short 3Ј-trailer sequence similar to that present in the product a3Ј. The end product of the in vitro processing reaction, product c, comigrated in a denaturing gel with the authentic U19 RNA purified from HeLa cells (Fig. 4C) . Incubation of product c with T4 RNA ligase resulted in its circularization (lane 3). These results show that product c represents faithfully processed U19 RNA bearing 5Ј-monophosphate and 3Ј-OH termini. The ladder of bands seen between products b and c indicates that the 3Ј trailer in product b is 9 nt long and that it is progressively removed by exonucleolytic activity. Enzymatic cleavage of 5Ј-end-labeled (A) and 3Ј-end-labeled (B) U19 RNA transcripts. The U19 transcript was synthesized in vitro; it contains two additional G residues at the 5Ј terminus, and one U residue was deleted from the 3Ј end to facilitate labeling of the RNA with [ 32 P]pCp (11) . RNA was subjected to a limited digestion, under nondenaturing conditions, with RNase T 1 (T1), A (A), or V1 (V1) and nuclease S1 (S1). Incubation times (minutes) are shown above the lanes. Guanosine-and adenosine-specific ladders (lanes G and A, respectively) were produced by partial digestions of U19 RNA with RNase T 1 or RNase U 2 under denaturing conditions. Lanes L, alkaline hydrolysis ladders. RNA fragments were resolved by denaturing PAGE (8% gel). Only two representative autoradiograms are shown; they do not illustrate all cleavages incorporated into the model shown in panel C. Sizes are indicated in nucleotides. (C) Proposed secondary structure of human U19 RNA. Nucleotides accessible to nuclease attacks are marked by nuclease-specific symbols. Sizes of symbols are proportional to the observed nuclease reactivity. (D) Sequence and proposed secondary structure of mouse U19 RNA. Nucleotides different from human U19 RNA are encircled; corresponding residues in human RNA are in lowercase. Ç, residues missing in human RNA.
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In addition to major processing products described above, two minor RNA products, a3Ј* and a5Ј(3Ј*), were observed (Fig. 4A) . These products contain unprocessed and fully matured 5Ј end, respectively. Mapping with the 3Ј probe showed that both these products retain the 45-nt-long trailer sequence (Fig. 4B) . The 3Ј-terminal region in products a3Ј* and a5Ј(3Ј*) has the potential to form an 11-bp hairpin (see the legend to Fig. 4A ), which could cause pausing of an exonuclease involved in processing of the RNA (25) .
U19 RNA is not associated with fibrillarin. Most of vertebrate snoRNAs are complexed with fibrillarin, and particles of which they are a part are precipitable with antifibrillarin antibodies. Unlike the control fibrillarin-associated U3 snoRNA, the U19 RNA was found predominantly among RNAs recovered from the supernatant of the immunoprecipitation reaction (Fig. 5A) . Traces of U19 RNA detected in the immunoprecipitate may represent a small fraction of U19 RNP associated with other, fibrillarin-containing snoRNPs. Autoimmune antibodies against the Th/To antigen, associated with the nucleolar 7-2/MRP RNA, also did not precipitate the U19 RNA (data not shown).
Of the two conserved sequence elements, box C (or CЈ) and box D, essential for binding of fibrillarin (3, 18, 44, 57) , human and mouse U19 RNAs lack box C, but both RNAs contain a short motif (GUCUGG; positions 183 to 188 and 184 to 189 in human and mouse RNAs, respectively), the sequences and positions of which are similar to those of genuine D boxes (consensus RUCUGA [56, 57] ). To determine whether the D-like box motif in U19 RNA is of functional importance, we tested the effects of mutations in this sequence on processing of U19 RNA in vivo. The GUCUGG sequence was mutated to GUCGAG, which diverges from the D box consensus in three 3Ј-proximal positions (point mutations in all of these positions were previously shown to affect accumulation of U14 RNA in yeast cells [18] ). The wild-type and mutant U19 sequences were inserted into the second intron of the human ␤-globin gene (25) , and resulting constructs were expressed in transfected mouse L929 cells. Accumulation of U19 RNA and of globin mRNA was assayed by RNase mapping using probes specific for each transcript. As shown in Fig. 5B , control and mutant U19 RNAs were processed from globin pre-mRNA with similar efficiencies (lanes 4 and 10), yielding RNAs identical in size to the authentic HeLa cell U19 RNA (lanes 2 and 7).
U19 RNA is associated with 65S higher-order structures in the nucleolus. HeLa cells were fractionated into cytoplasmic, nuclear, nucleoplasmic, and nucleolar fractions, and RNA isolated from each fraction was analyzed by RNase mapping using probes specific for U19 RNA and, as controls, probes specific for U13 snoRNA and U4 spliceosomal snRNA (Fig. 6A) . The U19 RNA, like U13 snoRNA (56) , cofractionated with the nucleolar fraction, while U4 snRNA was mainly found in the nucleoplasm. Taking the previously reported copy number of U4 RNA in HeLa cells (200,000 copies per cell [45] ) as a reference, the abundance of U19 RNA was estimated as 12,000 copies per cell.
In mammalian cells, snoRNAs U3, U8, U13, and U17 and 7-2/MRP RNA were shown to be associated with two different forms of RNPs (12, 25, 27, 37, 56) . Complexes sedimenting at 10S to 20S represent monomeric snoRNPs, while larger structures, sedimenting at 40S to 80S, probably correspond to snoRNPs bound to ribosomal particles undergoing maturation in the nucleolus. To analyze the U19 RNA-specific complexes, HeLa cell nucleolar extracts were fractionated on a 10 to 30% glycerol gradient. In addition to being present in the monoparticle-like fraction of 10S to 15S, the U19 RNA was found in association with higher-order structures of ϳ65S. For two other nucleolar RNAs analyzed as controls, the 7-2/MRP RNA was also reproducibly found in complexes sedimenting at ϳ65S, while U3 snoRNA was present in structures of ϳ80S VOL. 16, 1996 NON-FIBRILLARIN-ASSOCIATED U19 snoRNA 1395 cell and not nucleolar extracts, the 7-2/MRP RNA sediments at ϳ80S [27] [see the legend to Fig. 6 ].) DISCUSSION Most of the vertebrate snoRNAs characterized to date contain two short, conserved sequence elements referred to as boxes C and D, required for accumulation of the RNAs and also, directly or indirectly, for binding of fibrillarin. Apart from the 7-2/MRP RNA, only three vertebrate snoRNAs, U17/E1, E2, and E3, have been reported to lack the C and D boxes (8, 24, 48) . In S. cerevisiae, the family of snoRNAs apparently lacking these two elements is more complex; however, many of Aliquots were taken at intervals of 5 to 360 min, and RNA was fractionated on a 6% sequencing gel. Lanes S and C, substrate RNA incubated in the absence of the extract for 0 and 360 min, respectively. Sequences flanking the U19 RNA region in the U19/T7 substrate on the 5Ј and 3Ј sides are gggcgaAUUCAACUG AUACGUCUUCUACCUGGAGUGCCUAGGUAUCUGAAACAAAUAAU GAGAAAGCUGUUUCAGGAAUC. . . and . . .UUUUUCUGUUUGCAGA AAAAGACAGGUUGUCUUAGGGACAGCCUGUCAUUCUUUACCUC UUUGAAUCCUAGAUGCCUUCACCUGAAUGACAUCUACCUCCAUC AGGAtc, respectively. Nucleotides originating from the cloning vector are in lowercase, and those forming a potential hairpin (see text) are underlined. Lanes M, size markers. Schematic structure of the processing substrate and of the products characterized by RNase mapping (B) are shown on the right. (B) Characterization of the 5Ј and 3Ј ends of the in vitro processing products by RNase A-RNase T 1 mapping using unlabeled antisense RNA probes. Schematic structures of RNA probes and expected sizes of the protected fragments are shown at the bottom. Lanes P, aliquots of purified products, indicated at the top, used for RNase A-RNase T 1 mapping; lanes C, control mappings without added probe; lanes 5Ј and 3Ј, mappings with 5Ј and 3Ј probes, respectively; lanes M and L, size markers (the latter corresponding to G sequencing ladder). Products a3Ј* and a5Ј were obtained after 30 min of incubation, while others were obtained after 2 h of incubation. These products were isolated from a preparative gel similar to the one shown in panel A. Products c and b were not well separated from each other in the preparative gel. Each of them is a mixture of molecules bearing short (up to approximately 10 nt) 3Ј trailers, consistent with the data shown in panel A. Note that mapping of product a3Ј with the 3Ј-end-specific probe yielded a similar protection pattern, indicating that removal of the 3Ј trailer sequence may start before the processing of U19 RNA at the 5Ј end is completed. (C) Processing product c (lane 2) comigrates in a denaturing gel with the authentic U19 RNA (lane 1) and undergoes circularization upon incubation with the T4 RNA ligase (lane 3). Human U19 RNA was purified by hybrid selection, treated with calf intestine phosphatase, and 5Ј end labeled with T4 polynucleotide kinase in the presence of [␥- them are precipitable with antifibrillarin antibodies (reviewed in reference 37). In this study, we characterized a novel mammalian snoRNA, U19, which is not precipitable with antifibrillarin antibodies. The human and mouse U19 RNAs show 86% identity and have no significant sequence similarity to any of the snoRNAs so far characterized. The proposed secondary structure of U19 RNA, derived by partial digestion of the U19 RNA with different nucleases, also differs from structures proposed for other snoRNAs. The U19 RNA does not have a box C motif, and the presence of a D-like box sequence, GUCU GG, near the 3Ј end of U19 RNAs appears to be fortuitous, since its mutation has no effect on processing and accumulation of the RNA in transfected mouse cells. An intact D box was previously shown to be required for accumulation of U14 RNA in yeast cells (18) and U8 RNA in Xenopus oocytes (44) . Box D, together with other sequences and bound proteins, most probably forms part of the processing signal required for maturation of fibrillarin-associated intronic snoRNAs (2, 6, 36, 37) .
In vertebrates, most of the known snoRNAs are encoded within introns of protein-coding genes. These RNAs are not independently transcribed but are processed from introns of the host pre-mRNA (13, 32, 37, 52) . Several lines of evidence demonstrate that U19 RNA is a member of the family of intron-encoded snoRNAs. (1) U19 RNA contains a monophosphate at the 5Ј end, consistent with it being processed from a longer precursor RNA. (2) At the U19 genomic locus, the U19 RNA sequence is located within the intron of an as yet not fully characterized gene. (3) U19 RNA can be processed from a heterologous intron in transfected simian (25) or mouse (this work) cells. (4) U19 RNA is also faithfully processed in vitro from a longer intronic transcript, resulting in an RNA containing the 5Ј-monophosphate and 3Ј-OH termini. (5) From previous experiments (25) and this work (Fig. 4) , the processing of U19 RNA appears to be catalyzed by the 5Ј33Ј and 3Ј35Ј exonucleases, with the nucleotides immediately adjacent to the mature 3Ј end being removed relatively slowly. This processing pathway is similar to that established for two other intron-encoded snoRNAs, U17 (7, 24, 25) and U15 (57, 59) . Since non-fibrillarin-associated snoRNAs other than U17 and U19 also do not contain the 5Ј-terminal cap (42) , it is likely that all known members of this group of RNAs in vertebrates are intron encoded.
The coding regions of intronic snoRNAs appear to contain all information necessary for their faithful processing from host introns (25, 36, 37) . Many of the fibrillarin-associated intronic snoRNAs contain the helix-bulge-helix structures encompassing the C and D boxes and bringing together the 5Ј and 3Ј termini of the RNA (2, 57). These structures, together with associated proteins, probably act as processing signals arresting the progress of exonucleases (2, 6, 36, 37) . On the basis of the proposed secondary structure model, the 5Ј and 3Ј ends of U19 RNA are not base paired to each other. Other non-fibrillarin-associated snoRNAs (reference 8 and our unpublished observations), as well as some of the fibrillarinassociated snoRNAs (1), also lack the potential to form a terminal helix. Therefore, different structural elements must be responsible for processing of these snoRNAs. The structure of U19 RNA determined in this study will be of help in defining signals required for its maturation.
Many of the fibrillarin-associated snoRNAs contain long (up to 21 nt) sequences having complementarity to phylogenetically conserved regions in 18S or 25/28S rRNA (reviewed in references 1 and 2). In the case of U14 RNA, the complementarity was shown to be essential for pre-rRNA processing in S. cerevisiae (34) . A shorter complementary interaction, with the 5Ј external transcribed spacer, was also demonstrated to be important for the function of U3 snoRNA in S. cerevisiae (5) . Non-fibrillarin-associated RNAs U17, E2, and E3 do not generally contain long conserved sequences with the potential to base pair to pre-rRNA (8, 24, 47) . Interestingly, the U19 RNA has a potential to base pair with the 5Ј end of 5.8S rRNA. In humans, the sequence of 13 nt in U19 RNA (positions 143 to 145) can form 12 bp with 5.8S rRNA residues 3 to 15:
5.8S rRNA 5Ј-ACUCUUACGGUG-3Ј
U19 RNA 3Ј-UGAGAGUUCCAC-5Ј Similar 12-of-13 complementarity can also be drawn for mouse U19 and 5.8S RNAs. The significance of this observation, if any, is to be established.
Fractionation of HeLa cell nucleolar extracts on glycerol gradients revealed that, in addition to being present in monomeric snoRNPs of 10S to 15S, the U19 RNA is associated with higher-order structures sedimenting at ϳ65S. Preribosomal particles sedimenting at 65S and containing a precursor of 28S fractions of HeLa cells was analyzed by RNase mapping using probes specific for U19, U13, or U4 RNA. Lane C, control mappings with E. coli tRNA; lane M, size marker. The autoradiography of mappings with the U13 and U19 probes was for 20 h, and that with the U4 probe was for 2 h. To calculate the abundance of U19 RNA, corrections were made for different numbers of labeled C residues present in different probes. (B) Fractionation of the HeLa cell nucleolar extract on a 10 to 30% glycerol gradient. RNA was isolated from each of the 22 fractions and analyzed by RNase mapping using antisense RNA probes specific for U19, 7-2/MRP, or U3 RNA, as indicated on the right. Positions of the HeLa cell 40S, 60S, and 80S ribosomes, run in a parallel gradient, are indicated. Lane M, size marker. Sizes are indicated in nucleotides. Association of 7-2/MRP RNA with ϳ65S structures was confirmed in five independent experiments. However, it should be noted that previous analysis, performed with total cell and not nucleolar extracts, indicated that 7-2/MRP RNA sediments with ϳ80S and not ϳ65S structures (27) . Factors responsible for the differences in sedimentation properties, seen with two different extracts, are not known.
rRNA, several ribosomal proteins, and ribocharin, an isoelectric variant of the B23 protein (61) which transiently associates with maturing ribosomes, were previously identified in Xenopus oocytes (20) . The nucleoplasmic localization of Xenopus particles suggests that they represent immediate precursors of cytoplasmic 60S subunits on their way to the cytoplasm. The U19 RNA-containing complexes identified in the present work may represent precursors of 60S subunits still associated with the nucleolus, a possibility supported by the finding that 7-2/ MRP RNA is also present in complexes of similar size. In yeast cells, 7-2/MRP RNA is involved in the maturation of the large ribosomal subunit, catalyzing the processing of 5.8S rRNA, and it is likely that this RNA has a similar function in vertebrate cells (reviewed in references 37 and 40).
In summary, we have identified in mammalian cells a further U snoRNA which is not associated with fibrillarin. It will be interesting to establish whether snoRNAs belonging to this group share structural properties and interact with common proteins. Likewise, it will be important to characterize signals essential for processing of these snoRNAs from pre-mRNA introns and to define their role in ribosome biogenesis.
